This issue examines the diverse pharmaceutical marketing sector, with contributors analysing ethical issues, the need to strengthen theoretical foundations for greater understanding of the impact of activity in the sector, and policy implications relating to patient empowerment. A focus on online and social media is provided in several papers, highlighting the importance of this rapidly growing area.